The phrase "a means of optimizing" is correct and usable in written English.
It can be used when discussing methods or strategies for improving efficiency or effectiveness in a particular context.
Example: "Implementing a new software system is a means of optimizing our workflow and increasing productivity."
Alternatives: "a method for enhancing" or "a way to improve".
The results suggest a means of optimizing the local displacements, strains and stresses by controlling the material properties of the half-space boundary.
These two phenomena do not warrant an optimistic assessment for society's ability to engineer business law as a means of optimizing the challenges associated with innovation.
It was demonstrated on selected samples that using the free standard energy of wetting (ΔwetG°) provides a means of optimizing cell adhesion.
Direct blood flow measurement in the portal vein (PV) and in transjugular intrahepatic portosystemic shunts (TIPS) holds potential as a means of optimizing shunt creation and predicting outcomes.
One design innovation that provides a means of optimizing bridge girders for high strength material utilizes I-girders with double web plates.
IOASs are a means of optimizing the timing of diagnostic testing (in the case of in-office imaging) and treatment (in the case of in-office PT).
Another means of optimizing first-line therapy has been to examine whether superior treatment outcome is associated with specific patient or disease characteristics.
Increased attention is being placed on competency-based education as a means for optimizing the preparation of health professionals.
These results suggest a means for optimizing the nanostructural surfaces of polymer dielectrics by engineering OFET interfaces in an effort to improve device performance.
Examples of regenerative rehabilitation include the incorporation of physical activity to promote engraftment of stem cells into muscle tissue and the in vitro use of mechanical stimuli on cultured cells or tissues, as a means to optimize the efficacy of cell therapeutics and tissue engineering technologies.
For patients sustaining preinfusion sUA of less than 6 mg/dL, IRs occurred in fewer than 1 per 100 infusions.Phase 3 trial data combined with post hoc analyses demonstrated that knowledge of sUA preceding each pegloticase infusion and cessation of therapy when urate-lowering efficacy is lost provide a means to optimize the safety of pegloticase in clinical practice.
